
Eldorado Gold Co. (TSE:ELD – Free Report) (NYSE:EGO) – Investment analysts at Scotiabank dropped their FY2027 earnings per share estimates for Eldorado Gold in a research note issued to investors on Thursday, May 14th. Scotiabank analyst T. Jakusconek now anticipates that the company will earn $7.30 per share for the year, down from their previous forecast of $7.48. Scotiabank has a “Strong-Buy” rating on the stock. The consensus estimate for Eldorado Gold’s current full-year earnings is $2.15 per share.
A number of other brokerages have also recently issued reports on ELD. Stifel Nicolaus raised their price objective on Eldorado Gold from C$48.00 to C$65.00 in a research note on Tuesday, February 10th. ATB Cormark Capital Markets cut Eldorado Gold from a “moderate buy” rating to a “hold” rating in a report on Monday, May 4th. Royal Bank Of Canada lowered Eldorado Gold from a “moderate buy” rating to a “hold” rating and raised their price target for the stock from C$47.00 to C$48.00 in a research report on Tuesday, February 17th. Canadian Imperial Bank of Commerce downgraded Eldorado Gold from a “strong-buy” rating to a “hold” rating in a research report on Friday, February 20th. Finally, BMO Capital Markets set a C$82.00 price objective on Eldorado Gold and gave the company an “outperform” rating in a research note on Wednesday, April 15th. One investment analyst has rated the stock with a Strong Buy rating, two have given a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat, Eldorado Gold currently has an average rating of “Moderate Buy” and a consensus target price of C$63.50.
Eldorado Gold Stock Performance
Eldorado Gold stock opened at C$47.21 on Friday. The firm has a fifty day simple moving average of C$47.88 and a two-hundred day simple moving average of C$49.46. The company has a quick ratio of 2.28, a current ratio of 1.62 and a debt-to-equity ratio of 28.81. Eldorado Gold has a twelve month low of C$24.30 and a twelve month high of C$69.46. The company has a market capitalization of C$12.43 billion, a PE ratio of 16.86, a P/E/G ratio of 56.20 and a beta of 1.62.
Eldorado Gold (TSE:ELD – Get Free Report) (NYSE:EGO) last announced its quarterly earnings data on Thursday, April 30th. The company reported C$0.95 earnings per share (EPS) for the quarter. Eldorado Gold had a net margin of 28.71% and a return on equity of 13.69%. The company had revenue of C$740.23 million during the quarter.
Insider Activity
In other news, insider Paul Anthony Ferneyhough sold 6,808 shares of the stock in a transaction dated Wednesday, May 6th. The shares were sold at an average price of C$43.17, for a total transaction of C$293,901.36. Following the completion of the sale, the insider directly owned 43,940 shares in the company, valued at approximately C$1,896,889.80. This represents a 13.42% decrease in their ownership of the stock. Also, insider Christian Milau bought 12,400 shares of the business’s stock in a transaction that occurred on Tuesday, May 5th. The stock was acquired at an average cost of C$40.17 per share, for a total transaction of C$498,108.00. Following the completion of the purchase, the insider directly owned 43,273 shares of the company’s stock, valued at C$1,738,276.41. The trade was a 40.16% increase in their ownership of the stock. In the last quarter, insiders purchased 49,672 shares of company stock valued at $2,244,697 and sold 127,165 shares valued at $5,544,070. 0.58% of the stock is currently owned by insiders.
About Eldorado Gold
Eldorado Gold Corp is a gold and base metals producer with mining, development and exploration operations in Turkey, Canada, Greece and Romania. It has a portfolio of high-quality assets and long-term partnerships with local communities. Some of its projects include Kisladag, Efemcukuru, Skouries; Perama Hill and Certej projects.
Recommended Stories
- Five stocks we like better than Eldorado Gold
- Karman: Defense Darling’s Outlook Strengthens After 40% Drop
- Aeluma’s Post-Earnings Dip Creates a Buying Opportunity
- Be Ready: 3 Upcoming Catalysts Could Drive Oracle to Record Highs
- 2 Ways to Play the Big Pharma Patent Cliff
Receive News & Ratings for Eldorado Gold Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eldorado Gold and related companies with MarketBeat.com's FREE daily email newsletter.
